Clinical Trials Directory

Trials / Unknown

UnknownNCT04885946

Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Christian Hvas · Academic / Other
Sex
All
Age
18 Years – 130 Years
Healthy volunteers
Not accepted

Summary

Clostridioides difficile (CD) infection (CDI) is a global health threat with an urgent need for new treatment strategies. Faecal microbiota transplantation (FMT) is effective for recurrent Clostridioides difficile infection (CDI), and is currently recommended for multiple (three or more), recurrent CDI infections. The role of FMT earlier in the treatment hierarchy of CDI remains to be determined. In this randomized, double-blinded, placebo-controlled clinical trial, we compare FMT with placebo following standard antibiotic treatment for first or second Clostridioides difficile infection.

Detailed description

This is a parallel arm placebo-controlled clinical trial. We aim to include 84 adult patients with their first or second episode of Clostridioides difficile (formerly Clostridium difficile) infection. All patients receive vancomycin standard therapy. Patients are randomised in a 1:1 ratio to two treatments with capsules that contain either FMT+FMT or placebo+placebo. The primary outcome is absence of C difficile-associated disease 8 weeks after randomisation. Patients who have fulminant disease where it is deemed unethical to give placebo are offered open-label FMT. The primary outcome in patients with fulminant C difficile infection is 8 weeks mortality.

Conditions

Interventions

TypeNameDescription
OTHERFecal microbiota transplantion (FMT)Single donor, fecal microbiota transplantion (FMT) from healthy human donors.
OTHERPlaceboFood coloring, water, glycerol

Timeline

Start date
2021-06-02
Primary completion
2022-03-31
Completion
2024-12-31
First posted
2021-05-13
Last updated
2022-06-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04885946. Inclusion in this directory is not an endorsement.